Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Apr
5
2024
 Pharmaceutical Companies May Be the First Targets of the Washington State My Health My Data Act Greenberg Traurig, LLP
Apr
5
2024
 New York Cannabis Regulations Are (Initially Ruled) Unconstitutional, Says New York Judge ArentFox Schiff LLP
Apr
4
2024
 Proposal to Revamp Alabama Medical Cannabis Program Met with Near-Unanimous Opposition Bradley Arant Boult Cummings LLP
Apr
4
2024
 Cancer Drugs (Antibody Drug Conjugates): An FDA Perspective Foley & Lardner LLP
Apr
4
2024
 FDA Reminds Stakeholders of Animal Drug ‘Approved by FDA’ Labeling Requirements Greenberg Traurig, LLP
Apr
4
2024
 Take the Beer Goggles Off: Ambiguity Prevents Summary Judgment McDermott Will & Emery
Apr
4
2024
 CTP Releases New 5-year Strategic Plan Keller and Heckman LLP
Apr
4
2024
 AMS Requests Information to Update List of Bioengineered Foods Bergeson & Campbell, P.C.
Apr
3
2024
 FTC’s Campaign Against Improper Orange Book Listings Continues with Amicus Brief in Teva’s Challenge of Amneal Asthma Inhaler ANDA Sheppard, Mullin, Richter & Hampton LLP
Apr
3
2024
 EPA Describes Future of Its Nanotechnology Research Bergeson & Campbell, P.C.
Apr
3
2024
 FDA Warning Letter Is a Stark Reminder that if You Claim Your Product Is RUO, it Has to Be RUO Mintz
Apr
3
2024
 US FDA to Develop Regulatory Scheme for AI in Medical Products, Foster International Cooperation Greenberg Traurig, LLP
Apr
3
2024
 The “Fix” Is In: Alabama Legislature to Consider Controversial Proposal to Revamp Stalled Medical Cannabis Program Bradley Arant Boult Cummings LLP
Apr
3
2024
 FDA Revokes Standard of Identity for Frozen Cherry Pie Keller and Heckman LLP
Apr
3
2024
 This Week in 340B: March 19 – 25, 2024 McDermott Will & Emery
Apr
3
2024
 This Week in 340B: March 13 – 18, 2024 McDermott Will & Emery
Apr
3
2024
 New Florida Third-Party Food Delivery Law in Effect Greenberg Traurig, LLP
Apr
3
2024
 This Week in 340B: March 26 – April 1, 2024 McDermott Will & Emery
Apr
2
2024
 NIOSH Science Blog Item Highlights 20 Years of NTRC’s Field Studies Team Bergeson & Campbell, P.C.
Apr
2
2024
 Litigation Minute: Class-Action Challenges to Natural and Clean Beauty Product Claims K&L Gates LLP
Apr
2
2024
 Unpacking Averages: Adverse Events for Device-Lead Combination Products Epstein Becker & Green, P.C.
Apr
2
2024
 FSIS Updates Guidelines for Label Approval Keller and Heckman LLP
Apr
2
2024
 Soaring High on Hoverbikes: Look Ma, No Ground! Nishith Desai Associates
Apr
1
2024
 FDA: New Guidance for Non-interventional Studies of Drug Safety and Effectiveness Foley & Lardner LLP
Apr
1
2024
 Weed at Work: Can Georgia Employers Still Drug Test? Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
1
2024
 Recent Delaware Coverage Decisions on Relatedness Leaves D&O Claim Uncertainties Hunton Andrews Kurth
Apr
1
2024
 So, You’ve Been Sued in a Labeling Class Action. Now What? McDermott Will & Emery
Apr
1
2024
 FDCA Preemption: A Powerful Tool for Defending Class Actions Sheppard, Mullin, Richter & Hampton LLP
Displaying 757 - 784 of 11741
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins